Data / Form D filings / T3D Therapeutics, Inc.
T3D Therapeutics, Inc.: Form D filings
T3D Therapeutics, Inc., a pharmaceuticals company in Research Triangle Park, NC, filed 8 Form D notices with the SEC between 2013 and 2022. The latest, on September 6, 2022, reports $6 million sold of a $7.5 million offering to 23 investors.
Find out what T3D Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 68 T.W. Alexander Drive, Research Triangle Park, NC, 27709
- Phone
- (919) 949-0517
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1579600
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2022 | New notice | $7,500,000 | $6,002,712 | $1,497,288 | 23 | Aug 26, 2022 | sec.gov |
| Nov 1, 2019 | New notice | $15,000,000 | $15,000,000 | $0 | 1 | Oct 25, 2019 | sec.gov |
| Mar 12, 2018 | New notice | $18,000,000 | $6,000,000 | $12,000,000 | 1 | Mar 2, 2018 | sec.gov |
| Jan 12, 2018 | New notice | $1,000,000 | $711,270 | $288,730 | 30 | Jan 5, 2018 | sec.gov |
| Mar 14, 2016 | Amendment | $3,750,200 | $1,210,206 | $2,539,994 | 18 | Feb 26, 2015 | sec.gov |
| Mar 13, 2015 | New notice | $3,000,000 | $115,002 | $2,884,998 | 2 | Feb 26, 2015 | sec.gov |
| Mar 14, 2014 | New notice | $2,500,000 | $660,997 | $1,839,003 | 9 | Mar 1, 2014 | sec.gov |
| Aug 5, 2013 | New notice | $550,000 | $437,000 | $113,000 | 17 | Jun 19, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Donald Parker | Director | |
| John Didsbury | Executive Officer, Director, Promoter | |
| Tom Mendell | Director | |
| Charles Lineberry | Director | |
| Barry Buzogany | Director | |
| John Golden | Director | |
| David Keim | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Sep 5, 2022 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what T3D Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.